126 related articles for article (PubMed ID: 11275946)
1. A new generation IRMA for ACTH with improved specificity: validation in various physiological and pathological conditions.
Guiban D; Massias JF; Dugué MA; Coste J; Bertagna X; Raffin-Sanson ML
Eur J Endocrinol; 2001 Apr; 144(4):369-77. PubMed ID: 11275946
[TBL] [Abstract][Full Text] [Related]
2. Direct measurement of the precursors of adrenocorticotropin in human plasma by two-site immunoradiometric assay.
Crosby SR; Stewart MF; Ratcliffe JG; White A
J Clin Endocrinol Metab; 1988 Dec; 67(6):1272-7. PubMed ID: 2848055
[TBL] [Abstract][Full Text] [Related]
3. Discrimination between beta-endorphin and beta-lipotrophin in human plasma using two-site immunoradiometric assays.
Gibson S; Crosby SR; White A
Clin Endocrinol (Oxf); 1993 Oct; 39(4):445-53. PubMed ID: 8287571
[TBL] [Abstract][Full Text] [Related]
4. ACTH precursors characterize the ectopic ACTH syndrome.
Stewart PM; Gibson S; Crosby SR; Penn R; Holder R; Ferry D; Thatcher N; Phillips P; London DR; White A
Clin Endocrinol (Oxf); 1994 Feb; 40(2):199-204. PubMed ID: 8137518
[TBL] [Abstract][Full Text] [Related]
5. High plasma proopiomelanocortin in aggressive adrenocorticotropin-secreting tumors.
Raffin-Sanson ML; Massias JF; Dumont C; Raux-Demay MC; Proeschel MF; Luton JP; Bertagna X
J Clin Endocrinol Metab; 1996 Dec; 81(12):4272-7. PubMed ID: 8954027
[TBL] [Abstract][Full Text] [Related]
6. Malignant gastric carcinoid causing ectopic ACTH syndrome: discrepancy of plasma ACTH levels measured by different immunoradiometric assays.
Tsuchiya K; Minami I; Tateno T; Izumiyama H; Doi M; Nemoto T; Mae S; Kasuga T; Osamura RY; Oki Y; Hirata Y
Endocr J; 2005 Dec; 52(6):743-50. PubMed ID: 16410667
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of an immunoradiometric assay for succinylated ACTH].
Saveanu A; Barlier A; De Boissezon C; Kertesz G; Jean F; Argémi B; Cailla H; Jaquet P
Ann Endocrinol (Paris); 1999 Nov; 60(5):414-21. PubMed ID: 10615521
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of ACTH related peptides in ectopic Cushing's syndrome.
Oliver RL; Davis JR; White A
Pituitary; 2003; 6(3):119-26. PubMed ID: 14971736
[TBL] [Abstract][Full Text] [Related]
9. A new immunoradiometric assay for corticotropin evaluated in normal subjects and patients with Cushing's syndrome.
Raff H; Findling JW
Clin Chem; 1989 Apr; 35(4):596-600. PubMed ID: 2539271
[TBL] [Abstract][Full Text] [Related]
10. Gel chromatographic characterization of immunoreactive adrenocorticotropin in patients with ACTH hypersecretion.
Reincke M; Allolio B; Deuss U; Winkelmann W
Klin Wochenschr; 1989 Nov; 67(21):1096-100. PubMed ID: 2555628
[TBL] [Abstract][Full Text] [Related]
11. High precursor level in maternal blood results from the alternate mode of proopiomelanocortin processing in human placenta.
Raffin-Sanson ML; Massias JF; Ankotche A; Coste J; de Keyzer Y; Oliver C; Dumont C; Cabrol D; Ferré F; Bertagna X
Clin Endocrinol (Oxf); 1999 Jan; 50(1):85-94. PubMed ID: 10341860
[TBL] [Abstract][Full Text] [Related]
12. Comparative value of plasma ACTH and beta-endorphin measurement with three different commercial kits for the etiological diagnosis of ACTH-dependent Cushing's syndrome.
Tabarin A; Corcuff JB; Rashedi M; Navarranne A; Ducassou D; Roger P
Acta Endocrinol (Copenh); 1992 Apr; 126(4):308-14. PubMed ID: 1317630
[TBL] [Abstract][Full Text] [Related]
13. The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndrome.
Reimondo G; Paccotti P; Minetto M; Termine A; Stura G; Bergui M; Angeli A; Terzolo M
Clin Endocrinol (Oxf); 2003 Jun; 58(6):718-24. PubMed ID: 12780748
[TBL] [Abstract][Full Text] [Related]
14. The corticotropin-releasing hormone test in the diagnosis of ACTH-dependent Cushing's syndrome: a reappraisal.
Pecori Giraldi F; Invitti C; Cavagnini F;
Clin Endocrinol (Oxf); 2001 May; 54(5):601-7. PubMed ID: 11380490
[TBL] [Abstract][Full Text] [Related]
15. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.
Peterson ME; Orth DN; Halmi NS; Zielinski AC; Davis DR; Chavez FT; Drucker WD
Endocrinology; 1986 Aug; 119(2):720-30. PubMed ID: 3015556
[TBL] [Abstract][Full Text] [Related]
16. Two-site immunoradiometric assay for adrenocorticotrophin: a cautionary study about the reactivity to its precursor molecules.
Fukata J; Naitoh Y; Usui T; Nakaishi S; Nakai Y; Imura H
Endocrinol Jpn; 1989 Feb; 36(1):155-61. PubMed ID: 2543547
[TBL] [Abstract][Full Text] [Related]
17. Differential release of proopiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays.
Gibson S; Crosby SR; Stewart MF; Jennings AM; McCall E; White A
J Clin Endocrinol Metab; 1994 Apr; 78(4):835-41. PubMed ID: 8157708
[TBL] [Abstract][Full Text] [Related]
18. Comparative assessment of ACTH and lipotropin plasma levels in the diagnosis and follow-up of patients with Cushing's syndrome: a study of 210 cases.
Kuhn JM; Proeschel MF; Seurin DJ; Bertagna XY; Luton JP; Girard FL
Am J Med; 1989 Jun; 86(6 Pt 1):678-84. PubMed ID: 2543219
[TBL] [Abstract][Full Text] [Related]
19. A comparison of immunometric and radioimmunoassay measurement of ACTH for the differential diagnosis of Cushing's syndrome.
Lindsay JR; Shanmugam VK; Oldfield EH; Remaley AT; Nieman LK
J Endocrinol Invest; 2006 Dec; 29(11):983-8. PubMed ID: 17259795
[TBL] [Abstract][Full Text] [Related]
20. The limited value of the desmopressin test in the diagnostic approach to Cushing's syndrome.
Terzolo M; Reimondo G; Alì A; Borretta G; Cesario F; Pia A; Paccotti P; Angeli A
Clin Endocrinol (Oxf); 2001 May; 54(5):609-16. PubMed ID: 11380491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
